Skip to search formSkip to main contentSkip to account menu

Psoralen Ultraviolet A Therapy

Known as: PUVA Therapy, PUVA Therapies, Therapies, PUVA 
Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To compare the efficacy of narrowband UV-B (TL-01) phototherapy with oral 8-methoxypsoralen photochemotherapy (8-MOP… 
Highly Cited
2000
Highly Cited
2000
In patients with severe chronic atopic dermatitis (AD), both photochemotherapy [psoralen ultraviolet A (PUVA)] and narrow‐band… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To compare the therapeutic efficacy of narrowband (TL-01) UV-B phototherapy vs photochemotherapy (psoralen-UV-A [PUVA… 
Highly Cited
1999
Highly Cited
1999
It has been suggested that trioxsalen bath and ultraviolet (UV) A (PUVA) is associated with a very low or no risk of non‐melanoma… 
Highly Cited
1999
Highly Cited
1999
Furocoumarins are natural photosensitizing drugs used in PUVA photochemotherapy and in photopheresis. Their therapeutic… 
Review
1997
Review
1997
Oral psoralen plus UV-A (PUVA) therapy was originally developed for the treatment of vitiligo. 1,2 With the introduction of… 
Highly Cited
1996
Highly Cited
1996
REPORT OF A CASE A 42-year-old woman who suffered for more than 2 years from disseminated localized scleroderma (LS) (Figure 1… 
Highly Cited
1992
Highly Cited
1992
Summary Forty‐five patients with extensive chronic plaque or guttate psoriasis were treated with either narrowband (TL‐01… 
Highly Cited
1990
Highly Cited
1990
The therapeutic effectiveness of a new fluorescent lamp, Philips TL-01, which emits a narrow peak around 311-312 nm, was compared…